The foregut is constantly barraged with flora contaminating ingested substances. In order to ensure that digestion and absorption of nutrients is unimpeded, bacterial replications must be limited until the cecum is reached. Although the 'gastric acid barrier'effectively reduces bacterial counts in the stomach, many bacterial species can escape this barrier. Thus, additional defenses are in place to eradicate organisms resistant to gastric acid/pepsin. The most described secondary defenses include the antimicrobial peptides such as the defensins and cryptidins. Here, we describe for the first time in mammalian tissue, the function of surface oxidases, termed dual oxidase or DUOX, in the control of foregut bacterial colonization. Although these oxidases have been implicated in airway defense, and have been studied in drosophila and C. elegans intestine, there is no published report of their function in the mammalian gut. On the basis of our preliminary data and literature publications, we have formulated a hypothesis regarding how foregut bacteria activates DUOX through pattern recognition receptor (PRR) sensing, ATP signalling, purinoreceptor activation, and (Ca++)i increase, with H2O2 secreted into the lumen, which combined with secreted SCN- to form the strong oxidant, microbicidal anion OSCN-. This regulated system, for the secretion of microbicidal substances, which I will term the 'DUOX system', is likely to be an important foregut defense system against bacterial colonization with important pathogens. We propose to study Duox and PRR in the perfused anesthetized, rat and mouse intestine, measuring peroxide, ATP, and other released substances with standard assays. Knockout mice, when available, will be used to examine to function of individual components of the system. Since Duox is hypothesized to control foregut bacterial colonization, the proposed system may bear on several important diseases, such as small intestinal bacteria overgrowth (SIBO), cystic fibrosis, and inflammatory bowel disease.

Public Health Relevance

The proposed research, in which we intend to study how peroxide secreted by the intestine kills bacteria, bears on many important diseases that place a large burden on society. In particular, inflammatory bowel disease, irritable bowel syndrome, and cystic fibrosis are all diseases, all currently incurable, in which colonization with the wrong kind of bacteria can be causative. Malfunction of the peroxide-based antimicrobial system may be an important reason why these diseases cause so much tissue injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK054221-14A1
Application #
8438218
Study Section
Clinical, Integrative and Molecular Gastroenterology Study Section (CIMG)
Program Officer
Carrington, Jill L
Project Start
1999-05-01
Project End
2017-03-31
Budget Start
2013-04-10
Budget End
2014-03-31
Support Year
14
Fiscal Year
2013
Total Cost
$295,727
Indirect Cost
$46,037
Name
Brentwood Biomedical Research Institute
Department
Type
DUNS #
197170756
City
Los Angeles
State
CA
Country
United States
Zip Code
90073
Akiba, Y; Kaunitz, J D (2018) Gastric carbonic anhydrase IX deficiency: At base, it is all about acid. Acta Physiol (Oxf) 222:e13047
Kaunitz, Jonathan D (2018) Magnetic Resonance Imaging: The Nuclear Option. Dig Dis Sci 63:1100-1101
Kaji, I; Akiba, Y; Furuyama, T et al. (2018) Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon. Neurogastroenterol Motil 30:
Colina, Claudia; Puhl 3rd, Henry L; Ikeda, Stephen R (2018) Selective tracking of FFAR3-expressing neurons supports receptor coupling to N-type calcium channels in mouse sympathetic neurons. Sci Rep 8:17379
Akiba, Yasutada; Maruta, Koji; Narimatsu, Kazuyuki et al. (2017) FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. Am J Physiol Gastrointest Liver Physiol 313:G117-G128
Kaunitz, Jonathan D (2017) Development of Monoclonal Antibodies: The Dawn of mAb Rule. Dig Dis Sci 62:831-832
Kaji, Izumi; Kaunitz, Jonathan D (2017) Luminal chemosensing in the gastroduodenal mucosa. Curr Opin Gastroenterol 33:439-445
Said, Hyder; Akiba, Yasutada; Narimatsu, Kazuyuki et al. (2017) FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats. Dig Dis Sci 62:1944-1952
Kaji, Izumi; Akiba, Yasutada; Kato, Ikuo et al. (2017) Xenin Augments Duodenal Anion Secretion via Activation of Afferent Neural Pathways. J Pharmacol Exp Ther 361:151-161
Duboc, Henri; Tolstanova, Ganna; Yuan, Pu-Qing et al. (2016) Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons. Neurogastroenterol Motil 28:1663-1676

Showing the most recent 10 out of 87 publications